Age (SD) | 39.0 (8.7) |
Female (%) | 20 (51.3) |
College/university graduate (%) | 29 (77.3) |
HSV support group member (%) | 35 (89.7) |
Years since diagnosis (range) | 7 (0.5–24) |
Recurrences in past year (range) | 3 (0–18) |
RGHQoL score (range) | 20 (1–57) |
Antiviral drugs | |
Ever used antiviral drugs (%) | 30 (76.9) |
Ever used suppressive therapy (%) | 20 (51.3) |
Currently using antiviral drugs (%) | 13 (33.3) |
Ever hospitalised as a result of GH (%) | 2 (5.1) |
Current sex partner has GH* (%) | 13 (37.1) |
Experienced partnership break up as a result of GH (%) | 10 (26.4) |
Told GH could adversely affect childbearing† (%) | 11 (57.9) |
Pregnancy complicated by GH† (%) | 3 (15.8) |